Fortive Corp header image

Fortive Corp

FTV

Equity

ISIN null / Valor 32786609

New York Stock Exchange, Inc (2026-09-04)
USD 56.94-1.09%

Fortive Corp
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Fortive Corp is a diversified industrial technology company known for its focus on developing and deploying solutions across various sectors. The company operates through several business segments, including test and measurement, transportation technologies, and industrial technologies. Fortive's commitment to innovation is evident in its strategic market expansion into key global regions such as China, Japan, India, and the Middle East. The leadership team, including individuals with extensive experience in both Fortive and other notable organizations like Danaher Corporation, plays a crucial role in guiding the company's strategic direction and fostering a culture of continuous learning and growth. With a portfolio that addresses critical areas of operation for its clients, Fortive is positioned as a key player in the industrial technology space, leveraging its expertise to drive efficiency and productivity for businesses around the world.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (29.08.2026):

Fortive Corp reported results for the fourth quarter of 2025, delivering revenue of $1.12 billion (up 4.6% year‑over‑year; core revenue +3.3%), GAAP diluted EPS of $0.60 and adjusted diluted EPS of $0.90, and ending FY2025 with adjusted diluted EPS of $2.71 (exceeding the high end of guidance). The company generated strong adjusted EBITDA and free cash flow in Q4, executed substantial share repurchases, completed the Precision Technologies (Ralliant) separation, and initiated full‑year 2026 adjusted EPS guidance of $2.90–$3.00.

Q4 financials

Revenue $1,122.5M (+4.6% reported / +3.3% core); GAAP net income $192M (‑0.9% YoY); GAAP diluted EPS $0.60 (+7.1% YoY); adjusted diluted EPS $0.90 (+12.5% YoY); adjusted EBITDA $358M (+7.8% YoY).

Full‑year 2025 results

FY revenue $4,159.1M (+1.9% reported / +1.7% core); GAAP diluted EPS $1.59 (+16.1% YoY); adjusted diluted EPS $2.71 (+12.4% YoY) — above the high end of guidance; adjusted EBITDA $1,233M (+6.1%); Free Cash Flow $931M.

Cash flow & capital allocation

Q4 GAAP operating cash flow $344M and Free Cash Flow $314M. Fortive repurchased $265M of shares in Q4, ~$1.3B of buybacks in the second half (~26M shares, ~8% of diluted shares outstanding), and $1.6B of repurchases for FY2025 in total.

Segment performance

Intelligent Operating Solutions: Q4 revenue $769.7M (+5.3% / core +4.1%), adjusted EBITDA $288.1M (margin ~37.4%). Advanced Healthcare Solutions: Q4 revenue $352.8M (+3.2% / core +1.6%), adjusted EBITDA $91.7M with margin pressure versus prior year.

Guidance & strategy

Fortive initiated FY2026 adjusted diluted EPS guidance of $2.90–$3.00 and reiterated execution of its "Fortive Accelerated" strategy (organic growth via FBS Amplified, disciplined capital allocation, building investor trust) with the medium‑term financial framework intact.

Corporate actions

On June 28, 2025 Fortive completed the separation of its former Precision Technologies segment (Ralliant); the press release reports continuing operations results and discloses discontinued operations related to the PT Separation.

Summarized from source with an LLMView Source

Key figures

19.7%1Y
-27.9%3Y
-24.6%5Y

Performance

26.8%1Y
31.3%3Y
29.1%5Y

Volatility

Market cap

17197 M

Market cap (USD)

Daily traded volume (Shares)

2,249,886

Daily traded volume (Shares)

1 day high/low

75.22 / 74.1

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Kura Oncology Inc
Kura Oncology Inc Kura Oncology Inc Valor: 28160920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%USD 13.25
Robinhood Markets, Inc
Robinhood Markets, Inc Robinhood Markets, Inc Valor: 112476016
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.09%USD 122.11
Eckert & Ziegler SE
Eckert & Ziegler SE Eckert & Ziegler SE Valor: 433950
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%EUR 12.85
Applied Materials Inc
Applied Materials Inc Applied Materials Inc Valor: 908542
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.31%USD 454.71
Life360 Inc
Life360 Inc Life360 Inc Valor: 135781115
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.66%USD 44.17
MKS Instruments Inc
MKS Instruments Inc MKS Instruments Inc Valor: 616689
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.27%USD 260.31
GoDaddy Inc
GoDaddy Inc GoDaddy Inc Valor: 24674951
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 101.31
Entain PLC
Entain PLC Entain PLC Valor: 11238866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.38%GBP 5.28
INFICON HOLDING INC.
INFICON HOLDING INC. INFICON HOLDING INC. Valor: 1102994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.18%CHF 168.80
Accelleron Industries AG
Accelleron Industries AG Accelleron Industries AG Valor: 116936091
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.40%CHF 76.10